MindMed Investor Day Presentation Deck
June 2023, 61 slides
  1. MindMed
  2. Related Decks
  3. Investor Day Presentation Decks
investor presentation | MindMed
disclaimer | MindMed
today agenda | MindMed
at a glance a global leader in brain health | MindMed
lead candidate with evidence across multiple therapeutic areas | MindMed
brain health is one of the growing therapeutic areas | MindMed
us market revenue for gad by drug class million | MindMed
anxiety returning to focus as major driver of mental health disorders | MindMed
gad pipeline is far less crowded than pipeline | MindMed
legacy of clinical research in psychiatric disorders | MindMed
key drug candidate program | MindMed
advancing the field with strong strategic competitive moats | MindMed
table of contents unmet need patient journey in gad | MindMed
unmet need patient journey in gad maria | MindMed
an urgent need for better anxiety treatments | MindMed
anxiety correlated with significant impairment evidence of greater impairment for those with higher anxiety severity an anxiety disorder is also associated with less accomplishment at work reduced labor force participation associated with significantly higher rates of cardiac disorders hypertension gastrointestinal problems genitourinary disorders and migraine migraine | MindMed
need for additional treatment options is clear individual variations diverse gad is not a once size fits all indication it is a very occurring conditions depression or may complicate treatment resistance fail first line treatment side effects effects which reduce compliance current choices come with the potential for long term side disorder | MindMed
many patients change treatments due to lack of efficacy and or side effects | MindMed
patients are by current medications | MindMed
therapies offer promise evidence of rapid and durable impacts in anxiety and depression lesser concern for chronic safety issues monitored and infrequent dosing promises greater compliance | MindMed
practical aspects of monitored therapies table contents | MindMed
practical aspects of monitored therapies | MindMed
the neuropsychiatry institute founded to more effectively pursue cutting edge non invasive treatments for neuropsychiatric disorder specializing in depression anxiety eating disorders and related condition providing treatments clinical site for and compass pathways trials daily | MindMed
case study how therapy works at | MindMed
case study how therapy works at | MindMed
case study how therapy works at | MindMed
evolution of approval and launch to today | MindMed
the experience with therapy | MindMed
potential and promise of therapy potential for rapid long lasting relief from a variety of symptom we have years of experience and infrastructure for monitoring multiple sessions simultaneously through our work with and as well as a participant in and compass trial while the monitoring session would potentially be longer than with and shorter due to session total monitoring time is much with profitability will come additional sites willing to administer and monitor the treatment symptoms trials | MindMed
a for sessions and | MindMed
table of contents medication coverage | MindMed
payer considerations in new medication coverage | MindMed
behavioral health is a leading driver of costs | MindMed
depression and anxiety are most prevalent among us adults | MindMed
behavioral health issues tend to bring higher overall costs | MindMed
behavioral health is a priority for employers all employers want to address solutions for a a a | MindMed
factors for medication coverage determination approval clinical efficacy peer reviewed publications informative but not decisive specialty society guidelines subject matter expert opinion | MindMed
monitoring and administration coverage codes currently exist observation psychological evaluation evaluation and management sleep studies | MindMed
table of contents the landscape | MindMed
the landscape chad shear | MindMed
intellectual property in basics | MindMed
intellectual property in basics | MindMed
what can be patented | MindMed
what are the requirements for patentability novelty the invention should not have been previously known or used by in any public form such as in publications patents or public demonstration non obviousness the invention must involve an inventive step meaning it must not be obvious to a person skilled in the relevant utility the invention must have a specific and credible utility it should be useful and serve a practical purpose demonstrations field | MindMed
hatch waxman act orange book identifies drug products approved on the basis of safety and effectiveness by the food and drug administration under the federal food drug and cosmetic act the act and related patent and exclusivity month stay gives the brand product sponsor and patent holder a prescribed amount of time to assert patent rights in court before a generic competitor is approved and can market the drug information | MindMed
table of contents corporate update | MindMed
we seen positive momentum across the business | MindMed
our leadership team ava tufts | MindMed
our leadership team | MindMed
research development pipeline | MindMed
increases neural connectivity and activity | MindMed
legacy of clinical research in psychiatric disorders | MindMed
modern preliminary evidence in anxiety disorders | MindMed
modern preliminary evidence in depression | MindMed
phase generalized anxiety disorder gad | MindMed
phase enrollment update over next update | MindMed
potential clinical care model | MindMed
digital to complement delivery through the patient journey | MindMed
potential pathway to commercial success | MindMed
business highlights | MindMed
a | MindMed
See More
MindMed
Investor Day Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Anxiety
Delivery
Behavioral
Recent decks by MindMed
Investor Presentation
January 2025
Investor Presentation
December 2024
Investor Presentation
November 2024
Results
November 2023
See all presentations by MindMed (10 decks)
Related decks
Talkspace
Investor Conference
January 2024
UpHealth
SPAC
November 2020
Teladoc
Mergers and Acquisitions
September 2020
Taysha
IPO
September 2020
Talkspace
Investor Conference
January 2023
Talkspace
Results
August 2022
Dare Bioscience
Investor Presentation
February 2023
ATAI
Investor Presentation
October 2022
Recent decks by MindMed
See all presentations (10 decks)
Investor Presentation
January 2025
Investor Presentation
December 2024
Investor Presentation
November 2024
Results
November 2023
Talkspace
Investor Conference
January 2024
UpHealth
SPAC
November 2020
Teladoc
Mergers and Acquisitions
September 2020
Taysha
IPO
September 2020
Talkspace
Investor Conference
January 2023
Talkspace
Results
August 2022
Dare Bioscience
Investor Presentation
February 2023
ATAI
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights